ATHENA CAR-T
EDI-901-SLE01
Phase 1 mab active
Quick answer
ATHENA CAR-T for Lupus Erythematosus, Systemic is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Lupus Erythematosus, Systemic
- Phase
- Phase 1
- Modality
- mab
- Status
- active